FDA Requests Comment on Proposed Collection of Information for Labeling of Natural Rubber Latex Condoms

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, related to the development of draft guidance for industry and FDA staff on labeling for natural rubber latex condoms classified under 21 CFR 884.5300.